Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update
Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update GlobeNewswire November 06, 2025 – Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer – – Expects to report an update from the Phase 2 CRDF-004 trial in […]